Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Stock Markets Trading Flat
Thu, 8 Aug 11:30 am

The Indian stock markets have traded flat in the last two hours of trade. However, most of the sectoral indices are trading in the green with the Auto and Realty sectors leading the gains. On the other hand the Pharma and Power sectors are the top losers.

The BSE-Sensex is up by 20 points while NSE-Nifty is up by 10 points. BSE Mid Cap index and BSE Small Cap index are up by 0.67% and 0.94% respectively. The rupee was trading at 61.07 to the US dollar at the time of writing.

Many Pharma stocks are trading in the red today, led by Sun Pharma and GSK Pharma. Ranbaxy and Biocon are amongst the gainers today.

GSK Pharma is trading down 3% today. The company had reported disappointing numbers for Q1FY14 with profits falling nearly 30%. In a filing made to the BSE the company said its sales and turnover would be impacted by 5% on an annualised basis due to the implementation of the new prices of its medicines as notified by the government under the new Drug Price Control Order (DPCO) 2013. As per the policy, the span of price control of drugs has been enhanced from 74 to 348 drugs and the pricing mechanism has been amended from cost based pricing to market based pricing.

A number of drugs produced by the company have now come under the DPCO and this would result in the reduction of prices of these drugs. A number of companies like Cipla and Sun Pharma and Lupin have approached the courts against the order. However GSK Pharma has not.

All Auto stocks are trading positive today. Eicher Motor and Maharashtra Scooters are leading the gains. Tata motors declared its 1QFY14 results yesterday. The performance was largely driven by good show of its subsidiary Jaguar Land Rover (JLR). The company's consolidated sales grew by 8% YoY helped by a favorable exchange rate and a better product mix at JLR. It maintained its margins at 14.4%, same as last year. The consolidated net profit de grew by 23% YoY. Standalone entity performed poorly with decline in sales by 13% YoY. The EBITDA margin for the quarter dropped to 2.3% YoY. Profit after tax on standalone basis look inflated at Rs 7bn as it included dividend from JLR and other subsidiaries of around Rs 15.4bn, as against last year's profit of Rs 2.1 bn. Tata motors' stock is slightly up by 0.16% today.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian Stock Markets Trading Flat". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.